版本:
中国

BRIEF-Gemphire Therapeutics reports departure of CEO

May 30 Gemphire Therapeutics:

* Gemphire Therapeutics announces departure of its chief executive officer Mina Sooch

* Gemphire Therapeutics Inc- ‍steven Gullans named interim president and chief executive officer until a search for his replacement is completed​

* Gullans is managing director at excel Venture Management, Llc, which owns more than 5 pct of Gemphire's outstanding stock Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐